ポルテントールの高度に収束し,バイオミメティックな総合成
1Department of Chemistry and Center for Integrated Protein Science, Ludwig-Maximilians-Universität München , Butenandtstrasse 5-13, 81377 München, Germany.
Journal of the American Chemical Society
|October 17, 2015
まとめ
研究者らは異常なポリケチドポレントールの 効率的な合成を報告した. 主なステップには,ボロンアルドール反応とバイオミメティックサイクリングカスケードが含まれ,ポレントールとアンヒドロポレントールが得られました.
科学分野:
- 有機化学
- 自然製品合成
- ポリケチド化学
背景:
- ポルテントールは複雑な構造を持つ珍しいポリケチドです.
- ポリケチドの合成は,そのステレオ化学的複雑性のために重要な課題を提示する.
研究 の 目的:
- 自然産物ポレントールの 効率的な合成を開発する
- ポリケチド核の構築のための生物模倣戦略を探求する.
主な方法:
- 3つのボロンアルドール反応を使って 線形炭素の骨組みを作りました
- 酸化によって開始された生物模倣の二重サイクルカスケードを使用した.
- ポルテントールとその脱水産物であるアンヒドロポルテントールを合成した.
主要な成果:
- 異様なポリケチドを 合成した
- 合成は2つの挑戦的な反反立体構造の構築を特徴づけた.
- バイオミメティック・カスケードは 効率的にポレントールとアンヒドロポレントールを生成した.
結論:
- 報告された合成は,ポレントールへの効率的な経路を提供します.
- この研究では,ポレントールの生合成と,生合成経路における重要な合成ステップの関連性について論じています.
関連する概念動画
Biosynthesis of Lipids
870
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
870
Combined Effects of Drugs: Synergism
7.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.4K
Pharmaceutical Equivalents
259
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
259
Prodrugs
4.7K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.7K
Production of Pharmaceuticals
59
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
59
Drug Biotransformation: Overview
4.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
4.2K


